SeraCare Customer Poster Talk Video with Data Presented by Asuragen
Next-generation sequencing (NGS) of liquid biopsies offers a minimally invasive alternative to solid tissue biopsies and a more holistic profile of intra- and inter-tumoral heterogeneity for therapy selection and disease monitoring.
Watch the video and download this free poster to learn:
- How reference materials that commute to the target sample type can help to optimize ctDNA profiling technology
- Why the Seraseq ctDNA v2 Reference Material most closely resembles native ctDNA in amplifiablity and molecular diversity
- How highly patient-like reference materials allowed confident quantification of trace levels of ctDNA
We developed a technology that is able to quantify these trace levels of ctDNA. And we were able to do so because we optimized around a standard that we were confident in—that represented the targeted sample type.
~ Brian C. Haynes, Associate Director of Bioinformatics – Asuragen
